Taxotere Patients Denied Their Right To Make An Informed Decision

Sanofi continues to ignore the 10-12 percent of their Taxotere patients that suffer permanent hair loss from taking the drug

Wednesday, April 24, 2019 - Sanofi, the maker of the anti-cancer chemotherapy drug Taxotere, is being sued by cancer survivors for failing to adequately warn them of the potential side effect of permanent hair loss. Permanent hair loss from Taxotere includes total body hair such as head hair, eyebrows, eyelashes, underarm hair, pubic, leg and arm hair, and also the nose and ear hair, essential for filtering dirt and chemicals from entering those orifices. Cancer patients are angered that European health officials were forewarned of Taxotere's hair loss side effect years ago but the US market was not was kept in the dark.

Taxotere warning of permanent hair loss was and is to this day buried in small print within a list of other common side effects such as nausea, vomiting, and fatigue and couched in vague and ambiguous language. If one reads carefully, however, Sanofi admits that permanent hair loss is one of the most common side effects of taking the drug. Sanofi writes "The most common side effects of TAXOTERE include: infections, low white blood cells (help fight infections), low red blood cells (anemia) and low platelets (help blood to clot), allergic reactions, changes in your sense of taste, shortness of breath, constipation, decreased appetite, changes in your fingernails or toenails, swelling of your hands, face or feet, feeling weak or tired, joint and muscle pain, nausea and vomiting, diarrhea, mouth or lip sores, hair loss: in some people, permanent hair loss has been reported, other." It is quite easy for a cancer patient to assume that any hair loss they were to experience would be temporary. Taxotere

For women suffering from permanent and total Taxotere hair loss, the disfigurement ranks up there with any other physical injury. Women want to know why they were not warned in advance of permanent hair loss and advised that they had the choice to take other, equally as effective cancer drug treatments. Taxotere owes its cancer-fighting efficacy to its increased toxicity, the same toxicity that permanently destroys hair follicles throughout the body. Rather than warn of the very real risks of permanent Alopecia, Taxotere patients were advised that "hair generally grows back."

It is easy to think of hair loss as merely a vanity issue and Sanofi themselves downplay the significance of total hair loss. In reality, women suffer a real financial loss when they are no longer able to go to work or to pursue their careers. Women suffer from the constant mental anguish of feeling unattractive to their partner and many reports their hair loss has led to divorce. Parents with Taxotere hair loss tell of the feeling that their children are embarrassed to be seen with them in public and the emotional distress this causes. Overall, permanent hair loss negatively affects every aspect of one's life for the worse. Women who have been denied their right to make an informed decision are consulting with Taxotere permanent hair loss lawyers to see if they qualify for real financial compensation for the ordeal that they are going through.

More Recent Taxotere Hair Loss Lawsuit News:

• Taxotere Alopecia Warning Limited to the Fine Print | 5/17/2019
• Women that have to undergo chemotherapy for the first time face great anxiety | 5/6/2019
• Patients Must Be Made Aware Of Taxotere's Three Major Side Effects | 4/18/2019
• Women Are Angry Over Sanofi Failing To Warn About The Possibility of Permanent Hair Loss | 4/12/2019
• Women Undergoing Cancer Treatments Are Taking Better Care of Themselves to Limit Hair Loss | 4/5/2019
• Taxotere Permanent Hair Loss Has Devastating Psychological Implications For Patients | 3/25/2019
• Taxotere Causes Alopecia Which Can Be Psychologically Damaging | 3/20/2019
• Drug Makers Need To Write Clearer, More Descriptive Drug Warnings Starting With Taxotere | 3/18/2019
• Taxotere Lawsuits May Teach Doctors a Valuable Lesson | 3/13/2019
• Taxotere Permanent Baldness Warning | 4/30/2018
• Taxotere Chemotherapy and Permanent Hair Loss | 4/26/2018
• Sanofi Sales Representatives Oversold Taxotere | 4/24/2018
• Scientific Study Confirms Permanent Taxotere Hair Loss | 4/12/2018
• Chemotherapy Drug Side Effects | 4/9/2018
• Cancer Doctors Fail to Warn Patients | 4/4/2018
• Taxotere's Psychological Side Effects | 3/13/2018
• Permanent Hair Loss Can Lead to Depression | 3/6/2018
• A Woman's Hair is Linked to Their Feminity | 2/23/2018
• Studies Indicate Taxotere Causes Permanent Hair Loss | 2/14/2018
• Taxotere's Ambiguous Hair Loss Warning | 2/5/2018
• Permanent Hair Loss Makes the Fear of Growing Old All Too Real | 12/29/2017
• Thousands of Women File Taxotere Hair Loss Lawsuits | 12/27/2017
• Taxotere Patients Psychological Trauma Result in Lawsuits Against Sanofi-Aventis | 12/22/2017
• Scientific Studies Point to Taxotere Hair Loss | 12/18/2017
• Cancer Patients Right to Make an Informed Decision | 12/13/2017
• How Women Think About Chemotherapy Hair Loss | 12/11/2017
• The Emotional Side Effects of Alopecia | 12/8/2017
• Taxotere May Cause Permanent Hair Loss | 12/4/2017
• Women Equate Baldness With Masculinity | 11/27/2017
• Symptoms of Permanent Hair Loss | 11/21/2017
• Taxotere's Warning May Have Come Too Late For Many | 11/15/2017
• Taxotere Benefits and Side Effects | 11/9/2017
• Women Were Not Given a Choice of Cancer Drugs | 11/1/2017
• The Impact of Permanent Hair Loss on Some Cancer Survivors | 9/29/2017
• The Emotional Side Effects of Permanent Hair Loss For Women Are All Too Real | 9/22/2017
• Taxotere is Highly Toxic and Causes Permanent Hair Loss | 9/15/2017
• 10-15 Percent of Cancer Patients Given Taxotere Develop Permanent Hair Loss | 9/8/2017
• Permanent Hair Loss From Taxotere is a Real Possibility | 9/1/2017
• Taxotere Permanent Hair Loss Lawsuits | 7/21/2017
• Permanent Hair Loss Caused by Taxotere | 6/26/2017
• Taxotere Warnings Now Include Permanent Hair Loss | 6/19/2017
• Taxotere Hair Loss Lawsuits Focus on Warning Label | 6/12/2017
• Permanent Hair Loss in Some Taxotere Users Delivers Secondary Blow to Cancer Patients | 6/5/2017

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.